Firstly, the PSA test displays low specificity due to the influence of multiple factors that increase PSA levels, such as benign prostatic hyperplasia or prostatitis [4], and it is not able to accurately distinguish clinically-relevant tumors from indolent cases. The gene discussed is KLK3; the disease is medical procedure.